Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.
about
Infection in Organ Transplantation.Aspergillus infections in transplant recipients.Fungal infections in transplant and oncology patients.Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational studyPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Risk factors for invasive fungal disease in heart transplant recipients.Fungal infections in solid organ transplantation.Invasive fungal infections and antifungal therapies in solid organ transplant recipients.Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome.Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Current options in antifungal pharmacotherapy.Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach.Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.Antifungal prophylaxis in solid organ transplant recipients.Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.Antifungal prophylaxis following heart transplantation: systematic review.Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.Antifungal prophylaxis in liver transplant recipients: one size does not fit all.Invasive fungal infection after heart transplantation: A 7-year, single-center experience.Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients.Aspergillosis in solid organ transplantation.Late-onset invasive aspergillosis in organ transplant recipients in the current era.IgG monitoring to identify the risk for development of infection in heart transplant recipients.Use of echinocandin prophylaxis in solid organ transplantation.Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients.Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety.Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipientsAn Approach to a Pulmonary Infiltrate in Solid Organ Transplant Recipients
P2860
Q30238810-AA6A9505-3D2D-4514-A885-624670CD5DCFQ33719294-65290A4F-9ACD-4765-8518-9407A3490662Q33896940-0FAF2EC6-114C-44E1-AAEF-A8DC908E7BEAQ33998703-19E1CD65-FCB1-489C-9A67-B1C86C6A374CQ34532546-005BE402-8A17-4126-8C73-F051E63D0752Q35240401-800077DD-F2C4-44A8-91C5-5A41554CAA29Q36382578-57F7AF48-439A-445F-A46E-E289B57D0674Q36872848-6A815CB2-25FD-49AE-B82C-B95B56443F90Q36939531-1D1C515B-74E8-48D8-926A-35C7FCB4A27CQ37098160-12323573-2F07-4252-97F6-4135FF2BCC73Q37151326-8045DC49-ED06-469E-BFA9-AE0DCD8FB4FAQ37323506-30ED5160-C67E-4787-B61B-6E474AD8A4B8Q37854721-C4CC1A69-51F4-4FE6-A8DE-876A9EA19F3AQ37879201-3A93B808-B555-429B-AB2F-F8DB1B736478Q37933366-DB5AADC1-4E6F-438D-9751-21AAA167D91BQ38166459-23009242-2EDF-4DF3-ADA4-E8734594783FQ38192768-91BD8D43-C468-4563-999A-A98CAD98E542Q38688900-BA341F49-44CC-4753-AF9C-A1F850FABB01Q38689823-4EDB638D-BCB5-4B05-9412-77B9F0EC0EB4Q39727899-9AA6A08C-E88E-4641-BD04-BB868A9CD6C2Q40413402-1F65D739-4CC7-4A6B-ABF1-52D05D3B7AC8Q41700108-01BD6933-1349-446B-A0F0-BBC394C99FCEQ42272291-CB6C8601-CA0D-4F9D-B102-ED7FE8D8C206Q44405749-A456C8F7-0A80-48EC-B6D3-8EF7731C745BQ44779610-74A52815-D56B-47BC-AEDD-CFBF8B59E781Q50169997-A7FC9AE3-B629-4A02-94B6-868262EB0917Q50897404-F29868C9-D001-4F10-961A-C9BBE6F9CCF3Q53159378-F768B340-E836-4E65-8895-92811741EB94Q57568967-BB163AB8-07D0-4337-9682-4A14FE989CBEQ57746058-AA05F8A0-393D-428F-9F66-7EAAD0473471
P2860
Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@en
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@nl
type
label
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@en
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@nl
prefLabel
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@en
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@nl
P2093
P2860
P1476
Risk factors of invasive asper ...... oral itraconazole prophylaxis.
@en
P2093
Claudia Rodríguez
Jesús Palomo
Juan F Yañez
María Jesús Domínguez
Patricia Muñoz
P2860
P304
P356
10.1111/J.1600-6143.2004.00390.X
P407
P577
2004-04-01T00:00:00Z